The aim of this study is to conduct a comprehensive bibliometric analysis of studies and clinical trials on ALK-TKIs in NSCLC over the past decade, in order to present an integrated overview of the developmental trajectory, current landscape, and emerging trends in ALK-TKI research for NSCLC treatment. The gene discussed is ALK; the disease is non-small cell lung carcinoma.